Literature DB >> 18265451

Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?

Carl Elliott1.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18265451

Source DB:  PubMed          Journal:  New Yorker        ISSN: 0028-792X


× No keyword cloud information.
  19 in total

1.  The myth of equipoise in phase 1 clinical trials.

Authors:  Adil E Shamoo
Journal:  Medscape J Med       Date:  2008-11-05

2.  Report of two double-blind randomized placebo-controlled pilot studies of a carbohydrate-rich nutrient mixture for treatment of seasonal affective disorder (SAD).

Authors:  David Mischoulon; Paola Pedrelli; Judith Wurtman; Mark Vangel; Richard Wurtman
Journal:  CNS Neurosci Ther       Date:  2009-09-21       Impact factor: 5.243

3.  What we worry about when we worry about the ethics of clinical research.

Authors:  David Wendler
Journal:  Theor Med Bioeth       Date:  2011-06

4.  Role of physicians in the pharmaceutical industry and clinical research organizations: take more pride in your work.

Authors:  Lutz Heinemann; Marcus Hompesch
Journal:  J Diabetes Sci Technol       Date:  2008-07

5.  Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.

Authors:  Matt Lamkin; Carl Elliott
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

6.  Appraising Harm in Phase I Trials: Healthy Volunteers' Accounts of Adverse Events.

Authors:  Lisa McManus; Arlene Davis; Rebecca L Forcier; Jill A Fisher
Journal:  J Law Med Ethics       Date:  2019-06       Impact factor: 1.718

7.  Captive to the Clinic: Phase I Clinical Trials as Temporal Total Institutions.

Authors:  Quintin Williams; Jill A Fisher
Journal:  Sociol Inq       Date:  2018-04-20

Review 8.  More than the money: a review of the literature examining healthy volunteer motivations.

Authors:  Leanne Stunkel; Christine Grady
Journal:  Contemp Clin Trials       Date:  2010-12-10       Impact factor: 2.226

9.  A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder.

Authors:  David Mischoulon; George I Papakostas; Christina M Dording; Amy H Farabaugh; Shamsah B Sonawalla; A Monica Agoston; Juliana Smith; Erin C Beaumont; Liat E Dahan; Jonathan E Alpert; Andrew A Nierenberg; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2009-08-25       Impact factor: 4.384

10.  Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials.

Authors:  Jill A Fisher; Lisa McManus; Megan M Wood; Marci D Cottingham; Julianne M Kalbaugh; Torin Monahan; Rebecca L Walker
Journal:  J Empir Res Hum Res Ethics       Date:  2018-10-08       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.